|4500 Main St. , Kansas City, MO 64111|
|Fund Manager||Team Managed|
The fund seeks long-term capital growth. Income is a secondary objective. Under normal market conditions, the portfolio managers will invest at least 80% of the fund s net assets in medium size companies. The portfolio managers consider medium size companies to include those whose market capitalizations at the time of purchase are within the capitalization range of the Russell 3000 Index, excluding the largest 100 such companies. The portfolio managers intend to manage the fund so that its weighted capitalization falls within the capitalization range of the members of the Russell Midcap Index. Though market capitalization may change from time to time, as of June 30, 2020, the capitalization ranges of the Russell 3000 Index, excluding the largest 100 companies, and the Russell Midcap Index were $41.0 million to $60.3 billion and $557.0 million to $48.0 billion, respectively. In selecting stocks for the fund, the portfolio managers look for companies whose stock price may not reflect the company s value. The managers attempt to purchase the stocks of these undervalued companies and hold each stock until the price has increased to, or is higher than, a level the managers believe more accurately reflects the fair value of the company. The fund may invest a portion of its assets in foreign securities when these securities meet the portfolio managers standards of selection. The portfolio managers may sell stocks from the fund s portfolio if they believe a stock no longer meets their valuation criteria, a stock s risk parameters outweigh its return opportunity, more attractive alternatives are identified or specific events alter a stock s prospects.
|Asset Type||% Of Allocation|
|Total Net Assets||100.99 M|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$0|
|Timeframe||Average Annual Current Performance Monthly As Of 08/31/2021||Average Annual Current Performance Quarterly As Of 06/30/2021||Avg Annual Current Performance Monthly As Of 08/31/2021||Avg Annual Current Performance Quarterly As Of 06/30/2021|
|Life Of Fund||
|Symbol||Company Name||% Of Assets|
|ZBH||ZIMMER BIOMET HOLDINGS INC||3.02%|
|BK||BANK OF NEW YORK MELLON CORP||2.54%|
|NTRS||NORTHERN TRUST CORP||2.19%|
|EMR||EMERSON ELECTRIC CO||2.10%|
|AAP||ADVANCE AUTO PARTS||1.98%|
|CAG||CONAGRA BRANDS INC||1.93%|
|DGX||QUEST DIAGNOSTICS INC||1.90%|
|UHS||UNIVERSAL HEALTH SERVICES INC||1.89%|
Join the Action Alerts PLUS Community today!
Stocks could drop 20% as fiscal stimulus is withdrawn and economic growth slows, a Morgan Stanley strategist says.
AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.
Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.
Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.
DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.
Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.
Jim Cramer discusses the market selloff, Evergrande, debt ceiling talks, the upcoming Federal Reserve meeting, Pfizer and more in his latest video interview with TheStreet.
Wynn Resorts faces regulatory uncertainty in Macau, but Morgan Stanley says the casino operator is still 'worth the risk.'
Tesla wants to expand its autonomous-driving effort to help cars make their way through cities, not just highways.
Stocks moving in premarket trading Monday include Pfizer, Netflix, Li Auto, AstraZeneca and Bank of America.